Updated:
Omron Healthcare
Omron Healthcare is the world's No. 1 blood pressure monitor brand, selling over 400 million devices globally.
Omron Healthcare
Omron Healthcare is a medical-device subsidiary of Japan's Omron Corporation, focusing on home-use blood pressure monitors, nebulizers, scales, and pain management products. The company claims over 400 million units sold globally and a No. 1 market share in home blood pressure monitors (per the firm's website, 2025). The firm's product range includes connected monitors that wirelessly sync with the OMRON Connect app, allowing users to track heart health and share data with physicians. It also offers devices that screen for atrial fibrillation during routine checks. Products cover upper arm, wrist, and wearable formats, targeting both consumer and professional channels. Geographically, Omron Healthcare serves North America and other regions via its parent's global reach. Omron Healthcare maintains a US headquarters in Lake Forest, Illinois. It does not disclose AUM, deployment, or staff count as a discrete entity. The company runs a philanthropic initiative through its 'Going for Zero' mission, aiming to eliminate heart attacks and strokes. No recent operational events within the last 24 months are publicly available. As a corporate subsidiary of a publicly traded parent, Omron Healthcare does not function as an allocator or investment vehicle. Its structural differentiator is its position within a global industrial conglomerate — its capital allocation is determined by Omron Corporation's strategic priorities, not independent investment decisions.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Lake Forest
Corporate office
Lake Forest, IL, United States
Sector focus
Frequently asked questions
Is Omron Healthcare a family office or investment firm?
No. Omron Healthcare is a medical-device subsidiary of Omron Corporation, a Japanese industrial conglomerate publicly traded on the Tokyo Stock Exchange. It does not function as an allocator, family office, or investment vehicle — it manufactures and sells consumer health products.
What is Omron Healthcare's primary product line?
The firm's core product is home-use blood pressure monitors, which it claims is the world's No. 1 brand with over 400 million units sold (per the firm's website, 2025). It also produces nebulizers, scales, and pain management devices. Many monitors are wireless and sync with the OMRON Connect app for data tracking and atrial fibrillation screening.
Where is Omron Healthcare headquartered?
The US headquarters is in Lake Forest, Illinois (per the firm's website). Omron Healthcare operates as a subsidiary of Omron Corporation, which is headquartered in Kyoto, Japan.
Does Omron Healthcare manage third-party capital?
No. Omron Healthcare does not manage outside investor capital. It is a product company funded by its parent, Omron Corporation. Disclosures for AUM, deployment, or team size are not applicable or not publicly available.
What are Omron Healthcare's main competitors?
The firm competes in the home health monitoring market with brands like Withings, iHealth, and Qardio. In the broader medical device space, it also competes with Philips and GE Healthcare's consumer health divisions.
What is Omron Healthcare's 'Going for Zero' mission?
The firm states a commitment to 'Going for Zero' — a goal of eliminating heart attacks and strokes through technology and consumer education (per the firm's website, 2025). This is a marketing and product-development philosophy, not a philanthropic foundation with separate financials.
Does Omron Healthcare invest in startups or do venture deals?
There is no public evidence that Omron Healthcare operates a corporate venture capital arm or makes independent investments. Its parent, Omron Corporation, has a venture unit (Omron Ventures), but that is a separate entity focused on industrial automation and sensing technologies, not consumer health.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: